Adrenal imaging

American Journal of Roentgenology

Volumn 194, Issue 6, 2010, Pages 1450-1460

  Blake, Michael A ^a   Cronin, Carmel G ^a   Boland, Giles W ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Adrenal cortical carcinoma imaging; Adrenal CT; Adrenal imaging; Adrenal lymphoma imaging; Adrenal MRI; Adrenal PET CT; Pheochromocytoma imaging

Indexed keywords

CONTRAST MEDIUM; CORTICOTROPIN; GADOLINIUM; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADRENAL CORTEX ADENOMA; ADRENAL CORTEX CARCINOMA; B CELL LYMPHOMA; COMPUTER ASSISTED TOMOGRAPHY; DENSITOMETRY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DIFFUSION WEIGHTED IMAGING; ECTOPIC CORTICOTROPIN PRODUCTION; HUMAN; MYELOLIPOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHEOCHROMOCYTOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; ADRENAL TUMOR; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC IMAGING; LYMPHOMA; METHODOLOGY; RADIOGRAPHY; SCINTISCANNING;

ADRENAL GLAND NEOPLASMS; ADRENOCORTICAL CARCINOMA; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC IMAGING; HUMANS; LYMPHOMA; MAGNETIC RESONANCE IMAGING; PHEOCHROMOCYTOMA; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77953249858     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/AJR.10.4547     Document Type: Review

References (74)

1. Boland GW, Blake MA, Hahn PF, Mayo-Smith WW. Incidental adrenal lesions: principles, techniques, and algorithms for imaging characterization. Radiology 2008; 249:756-775
2. Dunnick NR, Korobkin M. Imaging of adrenal incidentalomas: current status. AJR 2002; 179:559-568
3. Lam KY, Lo CY. Metastatic tumours of the adrenal glands: a 30-year experience in a teaching hospital. Clin Endocrinol (Oxf) 2002; 56:95-101
4. Mitchell IC, Nwariaku FE. Adrenal masses in the cancer patient: surveillance or excision. Oncologist 2007; 12:168-174
5. Bovio S, Cataldi A, Reimondo G, et al. Prevalence of adrenal incidentaloma in a contemporary computerized tomography series. J Endocrinol Invest 2006; 29:298-302
6. Song JH, Chaudhry FS, Mayo-Smith WW. The incidental adrenal mass on CT: prevalence of adrenal disease in 1,049 consecutive adrenal masses in patients with no known malignancy. AJR 2008; 190:1163-1168
7. Oliver TW Jr, Bernardino ME, Miller JI, Mansour K, Greene D, Davis WA. Isolated adrenal masses in nonsmall-cell bronchogenic carcinoma. Radiology 1984; 153:217-218
8. Libe R, Bertherat J. Molecular genetics of adreno-cortical tumours: from familial to sporadic diseases. Eur J Endocrinol 2005; 153:477-487
9. Frilling A, Tecklenborg K, Weber F, et al. Importance of adrenal incidentaloma in patients with a history of malignancy. Surgery 2004; 136:1289-1296
10. Kocijancic I, Vidmar K, Zwitter M, Snoj M. The significance of adrenal metastases from lung carcinoma. Eur J Surg Oncol 2003; 29:87-88
11. Szolar DH, Melvyn Korobkin M, Reittner P, et al. Adrenocortical carcinomas and adrenal pheochromocytomas: mass and enhancement loss evaluation at delayed contrast-enhanced CT. Radiology 2005; 234:479-485
12. Young WF Jr. The incidentally discovered adrenal mass. N Engl J Med 2007; 356:601-610
13. Russell C, Goodacre BW, vanSonnenberg E, Orihuela E. Spontaneous rupture of adrenal myelolipoma: spiral CT appearance. Abdom Imaging 2000; 25:431-434
14. Benitah N, Yeh BM, Qayyum A. Minor morphologic abnormalities of adrenal glands at CT: prognostic importance in patients with lung cancer. Radiology 2005; 235:517-522
15. Mayo-Smith WW, Boland GW, Noto RB, et al. State-of-the-art adrenal imaging. RadioGraphics 2001; 21:995-1012
16. Rozenblit A, Morehouse HT, Amis SE Jr. Cystic adrenal lesions: CT features. Radiology 1996; 201:541-548
17. Lee MJ, Hahn PF, Papanicolau N, et al. Benign and malignant adrenal masses: CT distinction with attenuation coefficients, size, and observer analysis. Radiology 1991; 179:415-418
18. Korobkin M, Giordano TJ, Brodeur FJ, et al. Adrenal adenomas: relationship between histologic lipid and CT and MR findings. Radiology 1996; 200:743-747
19. Caoili EM, Korobkin M, Francis IR, et al. Adrenal masses: characterization with combined unenhanced and delayed enhanced CT. Radiology 2002; 222:629-633
20. Boland GW, Lee MJ, Gazelle GS, et al. Characterization of adrenal masses using unenhanced CT: an analysis of the CT literature. AJR 1998; 171:201-204
21. Korobkin M, Brodeur FJ, Yutzy GG, et al. Differentiation of adrenal adenomas from nonadenomas using CT attenuation values. AJR 1996; 166:531-536
22. Korobkin M, Brodeur FJ, Francis IR, Quint LE, Dunnick NR, Londy F. CT time-attenuation washout curves of adrenal adenomas and nonadenomas. AJR 1998; 170:747-752
23. Szolar DH, Kammerhuber FH. Adrenal adenomas and nonadenomas: assessment of washout at delayed contrast-enhanced CT. Radiology 1998; 207:369-375
24. Pena CS, Boland GW, Hahn PF, Lee MJ, Mueller PR. Characterization of indeterminate (lipidpoor) adrenal masses: use of washout characteristics at contrast-enhanced CT. Radiology 2000; 217:798-802
25. Johnson PT, Horton KM, Fishman EK. Adrenal imaging with MDCT: nonneoplastic disease. AJR 2009; 193:1128-1135
26. Johnson PT, Horton KM, Fishman EK. Adrenal mass imaging with multidetector CT: pathologic conditions, pearls, and pitfalls. RadioGraphics 2009; 29:1333-1351
27. Hahn PF, Blake MA. Boland GW. Adrenal lesions: attenuation measurement differences between CT scanners. Radiology 2006; 240:458-463
28. Stadler A, Schima W, Prager G, et al. CT density measurements for characterization of adrenal tumors ex vivo: variability among three CT scanners. AJR 2004; 182:671-675
29. Johnson PT, Horton KM, Fishman EK. Adrenal imaging with multidetector CT: evidence-based protocol optimization and interpretative practice. RadioGraphics 2009; 29:1319-1331
30. Bae KT, Fuangtharnthip P, Prasad SR, Joe BN, Heiken JP. Adrenal masses: CT characterization with histogram analysis method. Radiology 2003; 228:735-742
31. Remer EM, Motta-Ramirez GA, Shepardson LB, Hamrahian AH, Herts BR. CT histogram analysis in pathologically proven adrenal masses. AJR 2006; 187:191-196
32. Jhaveri KS, Wong F, Ghai S, Haider MA. Comparison of CT histogram analysis and chemical shift MRI in the characterization of indeterminate adrenal nodules. AJR 2006; 187:1303-1308
33. Ho LM, Paulson EK, Brady MJ, Wong TZ, Schindera ST. Lipid-poor adenomas on unenhanced CT: does histogram analysis increase sensitivity compared with a mean attenuation threshold? AJR 2008; 191:234-238
34. Halefoglu AM, Bas N, Yasar A, Basak M. Differentiation of adrenal adenomas from nonadenomas using CT histogram analysis method: a prospective study. Eur J Radiol 2010; 73:643-651
35. Boland GW, Hahn PF, Pena C, Mueller PR. Adrenal masses: characterization with delayed contrast-enhanced CT. Radiology 1997; 202:693-696
36. Krestin GP, Steinbrich W, Friedmann G. Adrenal masses: evaluation with fast gradient-echo MR imaging and Gd-DTPA-enhanced dynamic studies. Radiology 1989; 171:675-680
37. Park BK, Kim CK, Kim B, Lee JH. Comparison of delayed enhanced CT and chemical shift MR for evaluating hyperattenuating incidental adrenal masses. Radiology 2007; 243:760-765
38. Blake MA, Kalra MK, Sweeney AT, et al. Distinguishing benign from malignant adrenal masses: multi-detector row CT protocol with 10-minute delay. Radiology 2005; 238:578-585
39. Boland GW, Blake MA, Holalkere NS, Hahn PF. PET/CT for the characterization of adrenal masses in patients with cancer: qualitative versus quantitative accuracy in 150 consecutive patients. AJR 2009; 192:956-962
40. 18F-FDG PET/CT. J Nucl Med 2004; 45:1340-1343
41. Blake MA, Slattery JM, Kalra MK, et al. Adrenal lesions: characterization with fused PET/CT image in patients with proved or suspected malignancy - initial experience. Radiology 2006; 238:970-977
42. Caoili EM, Korobkin M, Brown RK, Mackie G, Shulkin BL. Differentiating adrenal adenomas from nonadenomas using (18)F-FDG PET/CT: quantitative and qualitative evaluation. Acad Radiol 2007; 14:468-475
43. 18F-FDG PET/CT in the evaluation of adrenal masses. J Nucl Med 2006; 47:32-37
44. Bakheet SM, Powe J, Ezzat A, Rostom A. F-18-FDG uptake in tuberculosis. Clin Nucl Med 1998; 23:739-742
45. Boerner AR, Voth E, Theissen P, Wienhard K, Wagner R, Schicha H. Glucose metabolism of the thyroid in Graves' disease measured by F-18-fluoro- deoxyglucose positron emission tomography. Thyroid 1998; 8:765-772
46. 18F-FDG PET in characterizing adrenal lesions detected on CT or MRI. J Nucl Med 2001; 42:1795-1799
47. Jana S, Zhang T, Milstein DM, Isasi CR, Blaufox MD. FDG-PET and CT characterization of adrenal lesions in cancer patients. Eur J Nucl Med Mol Imaging 2006; 33:29-35
48. 18F-fluorodeoxyglucose positron emission tomography. AJR 1997; 168:1357-1360
49. Becherer A, Vierhapper H, Pötzi C, et al. FDG-PET in adrenocortical carcinoma. Cancer Biother Radiopharm 2001; 16:289-295
50. Leboulleux S, Dromain C, Bonniaud G, et al. Diagnostic and prognostic value of 18-fluorodeoxyglucose positron emission tomography in adreno-cortical carcinoma: a prospective comparison with computed tomography. J Clin Endocrinol Metab 2006; 91:920-925
51. Zettinig G, Mitterhauser M, Wadsak W, et al. Positron emission tomography imaging of adrenal masses: (18)F-fluorodeoxyglucose and the 11betahydroxylase tracer (11)C-metomidate. Eur J Nucl Med Mol Imaging 2004; 31:1224-1230
52. Shulkin BL, Thompson NW, Shapiro B, Francis IR, Sisson JC. Pheochromocytomas: imaging with 2-[fluorine-18] fluoro-2-deoxy-D-glucose PET. Radiology 1999; 212:35-41
53. Semelka RC, Shoenut JP, Lawrence PH, et al. Evaluation of adrenal masses with gadolinium enhancement and fat-suppressed MR imaging. J Magn Reson Imaging 1993; 3:337-343
54. Mayo-Smith WW, Lee MJ, McNicholas MM, Hahn PF, Boland GW, Saini S. Characterization of adrenal masses (15 cm) by use of chemical shift MR imaging: observer performance versus quantitative measures. AJR 1995; 165:91-95
55. Mitchell DG, Crovello M, Matteucci T, Peterson RO, Miettinen MM. Benign adrenocortical masses: diagnosis with chemical shift MR imaging. Radiology 1992; 185:345-351
56. Reinig JW, Stutley JE, Leonhurdt CM, Spicer KM, Margolis M, Caldwell CB. Differentiation of adrenal masses with MR imaging: comparison of techniques. Radiology 1994; 192:41-46
57. Outwater EK, Siegelman ES, Radecki PD, Piccoli CW, Mitchell DG. Distinction between benign and malignant adrenal masses: value of T1-weighted chemical shift MR imaging. AJR 1995; 165:579-583
58. Korobkin M, Lombardi TJ, Aisen AM, et al. Characterization of adrenal masses with chemical shift and gadolinium-enhanced MR imaging. Radiology 1995; 197:411-418
59. Israel GM, Korobkin M, Wang C, Hecht EN, Krinsky GA. Comparison of unenhanced CT and chemical shift MRI in evaluating lipid-rich adrenal adenomas. AJR 2004; 183:215-219
60. Haider MA, Ghai S, Jhaveri K, Lockwood G. Chemical shift MR imaging of hyperattenuating (< 10 HU) adrenal masses: does it still have a role? Radiology 2004; 231:711-716
61. Outwater EK, Siegelman ES, Huang AB, Birnbaum BA. Adrenal masses: correlation between CT attenuation value and chemical shift ratio at MR imaging with in-phase and opposed-phase sequences. Radiology 1996; 200:749-752
62. Fujiyoshi F, Nakajo M, Kukukura Y, Tsuchimochi S. Characterization of adrenal tumors by chemical shift fast-low angle shot MR imaging: comparison of four methods of quantitative evaluation. AJR 2003; 180:1649-1657
63. Tsushima Y, Takahashi-Taketomi A, Endo K. Diagnostic utility of diffusion-weighted MR imaging and apparent diffusion coefficient value for the diagnosis of adrenal tumors. J Magn Reson Imaging 2009; 29:112-117
64. Miller FH, Wang Y, McCarthy RJ, et al. Utility of diffusion-weighted MRI in characterization of adrenal lesions. AJR 2010; 194:459; [web]W179-W185
65. Faria JF, Goldman SM, Szejnfeld J, et al. Adrenal masses: characterization with in vivo proton MR spectroscopy-initial experience. Radiology 2007; 245:788-797
66. Schlund JF, Kenney PJ, Brown ED, et al. Adreno-cortical carcinoma: MR imaging appearance with current techniques. J Magn Reson Imaging 1995; 5:171-174
67. Klibanski A, Stephen AE, Greene MF, Blake MA, Wu CL, Case records of the Massachusetts General Hospital: case 36-2006 - a 35-year-old pregnant woman with new hypertension. N Engl J Med 2006; 355:2237-2245
68. Lee FT Jr, Thornbury JR, Grist TM, et al. MR imaging of adrenal lymphoma. Abdom Imaging 1993; 18:95-96
69. Miyajima A, Nakashima J, Baba S, Tachibana M, Nakamura K, Murai M. Clinical experience with incidentally discovered pheochromocytoma. J Urol 1997; 157:1566-1568
70. Blake MA, Kalra MK, Maher MM, et al. Pheochromocytoma: an imaging chameleon. Radio- Graphics 2004; 24[suppl 1]:S87-S89
71. Ramsay JA, Asa SL, van Nostrand AW, Hassaram ST, de Harven EP. Lipid degeneration in pheochromocytomas mimicking adrenal cortical tumors. Am J Surg Pathol 1987; 11:480-486
72. Blake MA. Krishnamoorthy SK, Boland GW, et al. Low-density pheochromocytoma on CT: a mimicker of adrenal adenoma. AJR 2003; 181:1663-1668
73. Remer EM, Miller FH. Imaging of pheochromocytoma. In: Blake MA, Boland G, eds. Adrenal imaging. New York, NY: Humana Press, 2009:109-124
74. Kim S, Salibi N, Hardie AD, et al. Characterization of adrenal pheochromocytoma using respiratory-triggered proton MR spectroscopy: initial experience. AJR 2009; 192:450-454